HOPKINTON, Mass., July 29, 2011 /PRNewswire/ — Caliper Life
Sciences, Inc. (NASDAQ:
CALP) today announced that its presentation at the Leerink
Swann Life Science Tools & Diagnostics Roundtable, will be
webcast on August 3, at 3:00 p.m. EDT. Kevin Hrusovsky,
President and CEO of Caliper, will be providing an update on the
company’s business and has been selected to be a panelist to
discuss the rapidly growing next generation sequencing market. The
live webcast can be accessed at http://wsw.com/webcast/leerink22/calp/.
An archived presentation will be available for 90 days.
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge
technologies enabling researchers in the life sciences industry to
create life-saving and enhancing medicines and diagnostic tests
more quickly and efficiently. Caliper is aggressively
innovating new technology to bridge the gap between in vitro assays
and in vivo results and then translating those results into cures
for human disease. Caliper’s portfolio of offerings includes
state-of-the-art microfluidics, lab automation and liquid handling,
optical imaging technologies, and discovery and development
outsourcing solutions. For more information please visit www.caliperLS.com.